by Vandana Singh | Apr 6, 2026 | General
Viridian Therapeutics Inc. (NASDAQ:VRDN) shares fell sharply Monday following topline Phase 3 data from Amgen Inc. (NASDAQ:AMGN) for TEPEZZA in thyroid eye disease (TED), intensifying competitive pressure in the space. Amgen Data Raises Competitive Pressure The Phase...
by Lekha Gupta | Apr 6, 2026 | General
Ondas Inc. (NASDAQ:ONDS) on Monday announced a major contract win for its subsidiary, 4M Defense, in a competitive tender for a large-scale demining project. The award is part of the Israel Ministry of Defense’s $1.7 billion Eastern Border Security Barrier initiative,...
by Evette Mitkov | Apr 6, 2026 | General
Strategy Inc (NASDAQ:MSTR) shares are trading higher on Monday as Bitcoin (CRYPTO: BTC) jumps back above $69,000, helped by reports of a possible U.S.–Iran ceasefire plan that could reopen the Strait of Hormuz. Strategy stock is showing exceptional strength. Why is...
by Vandana Singh | Apr 6, 2026 | General
Denali Therapeutics (NASDAQ:DNLI) shares are down on Monday as the company announced it has regained full rights to its investigational therapy DNL593 from Takeda Pharmaceutical Co. Ltd. (NYSE:TAK) Takeda Ends Drug Partnership For Strategic Reasons Takeda on Friday...
by Lekha Gupta | Apr 6, 2026 | General
Valaris Limited (NYSE:VAL) announced on Wednesday that it has secured a 1,064-day contract extension with Petrobras (NYSE:PBR) for the drillship VALARIS DS-4. • Valaris stock is showing weakness. Why are VAL shares declining? Secures Significant Contract Extension...
Recent Comments